pti-125
Small moleculeexperimental
Clinical trial activity
4 trials · 4 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
3
Phase 3
0
Phase 4
0
Earliest trial started Aug 18, 2017 (NCT03784300)
Timeline
Indications
Studied for
Mechanism of action
- Filamin-AINHIBITOR
FLNA inhibitor
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT04388254 | Phase 2 | Mar 16, 2020 | Cassava Sciences, National Institute on Aging (NIA) |
| NCT04079803 | Phase 2 | Aug 15, 2019 | Cassava Sciences, National Institute on Aging (NIA) |
| NCT03748706 | Phase 2 | Nov 30, 2018 | Cassava Sciences, National Institutes of Health (NIH) |
| NCT03784300 | Phase 1 | Aug 18, 2017 | Cassava Sciences, National Institutes of Health (NIH), Worldwide Clinical Trials |
Showing 4 of 4 trials
Page 1 / 1
Organizations
Research & Development (4)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Cassava Sciences | For profit | 4 | 4 | 2 | 2017 |
| National Institute on Aging (NIA) | Government | 2 | 0 | 1 | 2019 |
| National Institutes of Health (NIH) | Government | 2 | 0 | 2 | 2017 |
| Worldwide Clinical Trials | For profit | 1 | 0 | 1 | 2017 |
4 organizations
Page 1 / 1